These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159 [TBL] [Abstract][Full Text] [Related]
5. Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Durante W; Schini VB; Catovsky S; Kroll MH; Vanhoutte PM; Schafer AI Am J Physiol; 1993 Feb; 264(2 Pt 2):H617-24. PubMed ID: 8447474 [TBL] [Abstract][Full Text] [Related]
6. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor. Schini-Kerth VB; Fisslthaler B; Andersen TT; Fenton JW; Vanhoutte PM; Busse R Thromb Haemost; 1995 Sep; 74(3):980-6. PubMed ID: 8571333 [TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells. Schini VB; Durante W; Catovsky S; Vanhoutte PM J Vasc Res; 1993; 30(4):209-17. PubMed ID: 8357951 [TBL] [Abstract][Full Text] [Related]
8. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096 [TBL] [Abstract][Full Text] [Related]
9. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells. Schini VB; Durante W; Elizondo E; Scott-Burden T; Junquero DC; Schafer AI; Vanhoutte PM Eur J Pharmacol; 1992 Jun; 216(3):379-83. PubMed ID: 1385162 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine. Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778 [TBL] [Abstract][Full Text] [Related]
11. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism. Schini-Kerth VB; Fisslthaler B; Busse R Am J Physiol; 1994 Dec; 267(6 Pt 2):H2483-90. PubMed ID: 7528998 [TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881 [TBL] [Abstract][Full Text] [Related]
14. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Durante W; Schini VB; Kroll MH; Catovsky S; Scott-Burden T; White JG; Vanhoutte PM; Schafer AI Blood; 1994 Apr; 83(7):1831-8. PubMed ID: 8142651 [TBL] [Abstract][Full Text] [Related]
15. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. Schini VB; Vanhoutte PM J Pharmacol Exp Ther; 1992 May; 261(2):553-9. PubMed ID: 1374468 [TBL] [Abstract][Full Text] [Related]